Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193713
Status:
COMPLETED
Last Update Posted:
2015-01-16
First Post:
2005-09-11
Brief Title:
Bifeprunox in the Treatment of Schizophrenia
Sponsor:
Solvay Pharmaceuticals
Organization:
Solvay Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Schizophrenia |
Keywords:
| Name | View |
|---|---|
| double-blind study in the treatment of schizophrenia | View |